[go: up one dir, main page]

MX2017014414A - Metodo para la produccion de circovirus porcino y vacunas pcv2. - Google Patents

Metodo para la produccion de circovirus porcino y vacunas pcv2.

Info

Publication number
MX2017014414A
MX2017014414A MX2017014414A MX2017014414A MX2017014414A MX 2017014414 A MX2017014414 A MX 2017014414A MX 2017014414 A MX2017014414 A MX 2017014414A MX 2017014414 A MX2017014414 A MX 2017014414A MX 2017014414 A MX2017014414 A MX 2017014414A
Authority
MX
Mexico
Prior art keywords
porcine circovirus
pcv2
pcv2 vaccines
production
circovirus production
Prior art date
Application number
MX2017014414A
Other languages
English (en)
Other versions
MX394778B (es
Inventor
Lawrence Paulraj
Dumas Frederic
Original Assignee
Merial Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merial Inc filed Critical Merial Inc
Publication of MX2017014414A publication Critical patent/MX2017014414A/es
Publication of MX394778B publication Critical patent/MX394778B/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K39/12—Viral antigens
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/51—Medicinal preparations containing antigens or antibodies comprising whole cells, viruses or DNA/RNA
    • A61K2039/525—Virus
    • A61K2039/5252—Virus inactivated (killed)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies
    • A61K2039/55—Medicinal preparations containing antigens or antibodies characterised by the host/recipient, e.g. newborn with maternal antibodies
    • A61K2039/552—Veterinary vaccine
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10034—Use of virus or viral component as vaccine, e.g. live-attenuated or inactivated virus, VLP, viral protein
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2750/00—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA ssDNA viruses
    • C12N2750/00011—Details
    • C12N2750/10011—Circoviridae
    • C12N2750/10051—Methods of production or purification of viral material

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Microbiology (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Virology (AREA)
  • Immunology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

Esta invención se relaciona a un método para al producción rápida de PCV2 tal que se puede obtener un rendimiento óptimo del virus. Esta invención también se relaciona a la vacuna útil contra PCV2 que incluye el PCV2 propagado utilizando tal método.
MX2017014414A 2015-05-14 2016-05-13 Método para la producción de circovirus porcino y vacunas pcv2. MX394778B (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201562161457P 2015-05-14 2015-05-14
PCT/US2016/032323 WO2016183423A1 (en) 2015-05-14 2016-05-13 Method for porcine circovirus production and pcv2 vaccines

Publications (2)

Publication Number Publication Date
MX2017014414A true MX2017014414A (es) 2018-03-16
MX394778B MX394778B (es) 2025-03-21

Family

ID=56027254

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2017014414A MX394778B (es) 2015-05-14 2016-05-13 Método para la producción de circovirus porcino y vacunas pcv2.

Country Status (5)

Country Link
US (2) US9944904B2 (es)
EP (1) EP3294876A1 (es)
HK (1) HK1252427A1 (es)
MX (1) MX394778B (es)
WO (1) WO2016183423A1 (es)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
MX394778B (es) * 2015-05-14 2025-03-21 Boehringer Ingelheim Animal Health Usa Inc Método para la producción de circovirus porcino y vacunas pcv2.
CN107312746B (zh) * 2017-06-22 2020-10-16 中国农业科学院哈尔滨兽医研究所 一种猪圆环病毒2型的大规模全悬浮培养方法
CN108754019B (zh) * 2018-05-29 2022-04-08 华南农业大学 一种猪流行性腹泻病毒orf1基因全序列的扩增方法
CN109402043A (zh) * 2018-05-30 2019-03-01 金河佑本生物制品有限公司 全悬浮培养pk15细胞株的获得及其应用
CN111235089A (zh) * 2018-11-28 2020-06-05 成都天邦生物制品有限公司 一种细胞纯悬浮工艺生产猪圆环病毒2型（pcv2）的方法
CN110241090B (zh) * 2019-05-07 2023-10-13 江苏南农高科技股份有限公司 一种全悬浮细胞培养生产猪伪狂犬病毒抗原的方法
CN110208542A (zh) * 2019-05-09 2019-09-06 江苏南农高科技股份有限公司 一种猪圆环病毒2型的elisa抗原检测试剂盒及其检测方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US666027A (en) 1900-05-05 1901-01-15 Larkin S Safford Automatic switch.
US721137A (en) 1901-04-11 1903-02-24 Ira D Bate Feeding mechanism for husking-machines.
ZA927014B (en) 1991-09-20 1993-03-19 Akzo Nv Chicken anaemia agent vaccine.
US6610661B1 (en) 1996-10-11 2003-08-26 The Regents Of The University Of California Immunostimulatory polynucleotide/immunomodulatory molecule conjugates
UA78180C2 (uk) 1997-10-03 2007-03-15 Меріаль Кільцевий вірус свині типу ii, вакцини та діагностичні реагенти
US7192594B2 (en) 1997-10-03 2007-03-20 Merial Limited Postweaning multisystemic wasting syndrome and porcine circovirus from pigs
US6517843B1 (en) 1999-08-31 2003-02-11 Merial Reduction of porcine circovirus-2 viral load with inactivated PCV-2
FR2781159B1 (fr) 1998-07-06 2000-10-06 Merial Sas Vaccin circovirus et parvovirus porcin
US7211379B2 (en) 1997-10-03 2007-05-01 Merial Sas Prevention of myocarditis, abortion and intrauterine infection associated with porcine circovirus-2
US6391314B1 (en) 1997-10-03 2002-05-21 Merial Porcine circoviruses vaccines diagnostic reagents
KR100879650B1 (ko) 1997-12-11 2009-01-20 유니버시티 오브 사스카췌완 돼지로부터의 이유후 다기관계작용성 소모 증후군 바이러스
AU770002B2 (en) 1998-03-13 2004-02-12 University Of Georgia Research Foundation, Inc., The Vaccines against circovirus infections
FR2789695B1 (fr) 1999-02-11 2003-03-07 Merial Sas Vecteurs et vaccins viraux a base d'adenovirus porcins recombines et replicatifs
US6943152B1 (en) 1999-06-10 2005-09-13 Merial DNA vaccine-PCV
US6497883B1 (en) 1999-06-10 2002-12-24 Merial Porcine circovirus recombinant poxvirus vaccine
JP4038127B2 (ja) * 2001-03-27 2008-01-23 ユニバーシティ オブ サスカチュワン サーコウイルスの培養方法
CN1852735B (zh) 2003-07-24 2011-05-11 梅瑞尔有限公司 包含水包油乳液的疫苗制剂
EP1941903A1 (en) * 2007-01-03 2008-07-09 Boehringer Ingelheim Vetmedica Gmbh Prophylaxis and treatment of PRDC
DK2155246T3 (da) * 2007-05-11 2013-04-02 Temasek Life Sciences Lab Ltd Fremstilling af en homogen cellelinje højtolerant til porcine circovirus type 2 (pcv2)-infektion
US20090017064A1 (en) 2007-07-10 2009-01-15 Wyeth Methods and Compositions for Immunizing Pigs Against Porcine Circovirus
KR20110090711A (ko) * 2010-02-04 2011-08-10 녹십자수의약품(주) 신규한 돼지 써코바이러스 타입 2 및 그의 용도
TWI508974B (zh) * 2010-12-22 2015-11-21 Sbc Virbac Ltd 豬第二型環狀病毒(Porcine Circovirus Type 2)、含彼之免疫組合物、檢測套組及其應用
CN103100082B (zh) * 2013-01-17 2015-08-12 福州大北农生物技术有限公司 一种利用生物反应器制备猪圆环病毒2型灭活疫苗的方法
KR102409183B1 (ko) * 2013-10-02 2022-06-15 베링거 인겔하임 애니멀 헬스 유에스에이 인크. Ｐｃｖ2 ｏｒｆ2 단백질 변이체 및 이로 이루어진 바이러스 유사 입자
US10406027B2 (en) 2014-06-13 2019-09-10 Novartis Ag OCT transparent surgical instruments and methods
MX394778B (es) * 2015-05-14 2025-03-21 Boehringer Ingelheim Animal Health Usa Inc Método para la producción de circovirus porcino y vacunas pcv2.

Also Published As

Publication number Publication date
EP3294876A1 (en) 2018-03-21
US20160333322A1 (en) 2016-11-17
WO2016183423A1 (en) 2016-11-17
MX394778B (es) 2025-03-21
HK1252427A1 (zh) 2019-05-24
US20180201906A1 (en) 2018-07-19
US10519427B2 (en) 2019-12-31
US9944904B2 (en) 2018-04-17

Similar Documents

Publication Publication Date Title
MX2017014414A (es) Metodo para la produccion de circovirus porcino y vacunas pcv2.
CL2017000285A1 (es) Terapia combinada para el tratamiento de un paramixovirus
MA47515A (fr) Compositions immunogènes très puissantes
CO2017004119A2 (es) Partículas tipo virus modificadas de cmv
CR20160502A (es) Anticuerpos de hemaglutinina contra el virus de la influenza b y métodos de uso
BR112017008959A2 (pt) método para tratamento de uma doença.
MX2017001752A (es) Indoles para su uso en la infección por el virus de la gripe.
MX2021010060A (es) Produccion de virus en huevos aviares.
EA201790571A1 (ru) Пирролопиримидины для применения при инфекции, вызванной вирусом гриппа
MX2020004543A (es) Vacunas contra el zika, composiciones inmunogenicas y metodos que las utilizan.
CR20170005A (es) Derivados de insoindolina
CY1123267T1 (el) Κρυσταλλικες μορφες 2-(tpit-boytyλamino)-4-((1r,3r,4r)-3-yδpoξy-4-μεθυλοκυκλοεξυλαμινο)-πυριμιδινο-5-καρβοξαμιδιου
MX2016010059A (es) Anticuerpos útiles en la inmunización pasiva contra la gripe y composiciones, combinaciones y métodos para utilizarlos.
DOP2016000073A (es) Composiciones y métodos para inhibir la expresión del gen alas1
CU24579B1 (es) Proceso de preparación de una vacuna tetravalente atenuada contra el virus del dengue
MX2017011655A (es) Compuestos de aza-piridona y usos de estos.
CL2015001562A1 (es) Método para obtener una vacuna de mycoplasma.
UY36221A (es) Derivados de isoindolinona
BR112017003891A2 (pt) métodos e composições para induzir imunidade protetora contra infecção por filovírus
MX2017005524A (es) Metodos y composiciones para el virus del dengue recombinante para el desarrollo de vacunas y de diagnostico.
UA116697C2 (uk) Композиція для запобігання зараженню видами роду mycoplasma
MX2019007252A (es) Metodos y composiciones para vacunas del virus del dengue.
BR112016019389A8 (pt) Vacina, e, peptídeo
MX2015015428A (es) Eliminacion de riesgo de narcolepsia en vacunas contra influenza.
BR112018008045A2 (pt) micro-organismo recombinante que produz l-treonina e um método para produzir l-treonina com o uso do mesmo